DJIA 18,288.63 155.93 0.86%
NASDAQ 5,008.10 44.57 0.90%
S&P 500 2,117.39 12.89 0.61%
market minute promo

Exelixis (NASDAQ: EXEL)

3.09 0.16 (5.46%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

EXEL $3.09 5.46%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.97
Previous Close $2.93
Daily Range $2.93 - $3.10
52-Week Range $1.26 - $7.58
Market Cap $603.2M
P/E Ratio -2.12
Dividend (Yield) $0.00 (0.0%)
Volume 4,469,090
Average Daily Volume 4,642,634
Current FY EPS -$0.89




Drug Makers

Exelixis (EXEL) Description

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. Website:

News & Commentary Rss Feed

Looking Ahead at Exelixis, Inc.

The biotech faces two major value-creating events in 2015.

Exelixis (EXEL) Shares March Higher, Can It Continue? - Tale of the Tape

Exelixis (EXEL) Shares March Higher, Can It Continue? - Tale of the Tape

XBI, FMI, EXEL, HALO: Large Inflows Detected at ETF

Exelixis' (EXEL) CEO Mike Morrissey on Q4 2014 Results - Earnings Call Transcript

Exelixis (EXEL) Q4 2014 Results - Earnings Call Webcast

Will Exelixis (EXEL) Miss Estimates this Earnings Season? - Analyst Blog

Why Shares of Exelixis, Inc. Briefly Spiked Higher

Exelixis shares popped briefly Thursday. Here's why.

Morning Market Gainers

Benzinga's Top #PreMarket Gainers

Even With Recent Exelixis Price Action, Outlook Remains Unchanged

See More EXEL News...

EXEL's Top Competitors

EXEL $3.09 (5.46%)
Current stock: EXEL
TMO $131.35 (1.04%)
Current stock: TMO
ILMN $194.06 (-0.72%)
Current stock: ILMN
WAT $121.36 (0.81%)
Current stock: WAT